20 results
8-K
EX-10.2
CCCC
C4 Therapeutics Inc
30 May 23
Entry into a Material Definitive Agreement
7:30am
as exhibits to the Company SEC Documents (as defined below).
4.2 Capitalization and Voting Rights.
(a)The authorized capital of the Company as of the date
PRE 14A
CCCC
C4 Therapeutics Inc
18 Apr 23
Preliminary proxy
7:59am
with our Series B preferred stock financing, we entered into an investors’ rights agreement containing registration rights, information rights, voting … rights and rights of first refusal, among other things, with certain holders of our preferred stock and common stock. The registration rights set
S-3ASR
e0y4cm2c1vef65d5
10 Nov 21
Automatic shelf registration
5:19pm
424B4
i1wvi
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
j4s e45lafubf6evua0r
19 May 21
Draft registration statement
12:00am
DEF 14A
vo6vw3n nvd
26 Apr 21
Definitive proxy
4:22pm
10-K
EX-4.4
iyjcin7u
11 Mar 21
Annual report
4:19pm
10-Q
1bfv1snhhecyx0ywgek
12 Nov 20
Quarterly report
4:28pm
424B4
zhy4tppxd1nuehl
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1
kiygfsgogt 7a7ni
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.1
sjipel lbv
10 Sep 20
IPO registration
5:26pm
S-1
EX-3.5
t1vuzc0m07 mrq92ghp
10 Sep 20
IPO registration
5:26pm
DRS
ta0q8f9
6 Aug 20
Draft registration statement
12:00am
DRS
EX-10.1
gje62pnstjzy8oyq
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next